Deeper explainers that connect the compounds, each grounded in the cited research.
Every next-generation weight-loss peptide explained: the triple agonists, GLP-1/GIP and GLP-1/glucagon duals, amylin drugs, oral GLP-1s, and muscle-preserving agents, with their mechanisms, trial results, and status.